Renal Flashcards

1
Q

eGFR is calculated from

A

Creatinine
Age
Gender
Ethnicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When is eGFR not valid

A

<18
Pregnancy (because kidney function varies)
AKI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Causes of pre-renal AKI (most common cause of AKI)

A

hypovolaemia
haemorrhage
sepsis
renal artery occlusion

made worse by:
drugs that lower BP (ACEi, ARBs, NSAIDs, loop diuretics), HF, third spacing of fluid (severe pancreatitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Causes of intrinsic AKI

A

Glomerulonephritis
Non-ischaemic ATN - drugs, myoglobin, paraproteins
Ischaemic ATN
Interstitial nephritis e.g. due to autoimmune disease, pyelonephritis, drugs
Vascular diseases like microangiopathic haemolytic anaemias (e.g. DIC) and malignant HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Post-renal causes of AKI

A
Stones
Lymphoma
Genitourinary tract rumours
Prostate hyperplasia
Strictures
Urinary retention
Blocked catheter
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Presentation of AKI

A

May be none - you can lose a lot of kidney function before symptoms show

are usually non-specific and related to the underlying disease

E.g. nausea, vomiting, diarrhoea, dehydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Stage 1 AKI

A

creatinine 1.5-1.9x baseline
or
<0.5ml/kg/h for 6-12 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Stage 2 AKI

A

creatinine 2-2.9x baseline
or
urine output <0.5ml/kg/h for >12 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Stage 3 AKI

A
creatinine >3x baseline 
or 
indication for RRT
or 
urine output <0.3ml/kg/h for >24 hours 
or anuria for >12 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Risk factors for AKI

A
>65
History of AKI
CKD (<60ml/min/1.73m2)
Renal disease
DM
Sepsis
CT diseases
HF
Liver disease
Use of nephrotoxic drugs
Iodinated contrast use in last week

NICE say to measure serum creatinine in all adults with acute illness and one of the risk factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Investigations for AKI

A

full A- E assessment
take a full history to try to determine cause
particular attention to volume status - peripheral perfusion, skin turgor, changes in urination pattern

BLOOD

  • ABG/VBG for metabolic acidosis
  • FBC - anaemia in CKD, leukocytosis in infection
  • creatinine - compare to baseline. and repeat 48-72 hours later
  • ratio of serum urea to creatinine (>20:1 supports pre-renal)
  • CRP and ESR
  • blood culture if sepsis
  • immunology - ANCA, ANA, anti-GBM, paraprotein
  • can do antistreptolysin O titre but strep infection rare now

URINE

  • urinalysis
  • urine culture if there is suspicion of infection on urinlaysis
  • albumin:creatinine ratio
  • urine osmolality

IMAGING

  • renal US - dilated renal calyces suggest obstruction, sclerotic kidneys suggest CKD
  • CXR if associated with HF
  • ECG with hyperkalaemia
  • renal vascular assessment required MRA (angiography) or renal doppler

OTHER
- do a fluid challenge - will improve rapidly in pre-renal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

managment of AKI

A

regularly assess urine output which may require a catheter
serial U+Es daily (increase if more severe)
stop nephrotoxic drugs and alter regular prescriptions to reflect change in creatinine clearance
treat hyperkalaemia
fluid challenge - 250-500ml saline over 30 mins
repeat if still dehydrated
once replete, continue fluid at 20ml + previous hour’s urine output per hour
if overloaded, consider urgent dialysis
or, if passing urine then can give diuresis as treatment
treat sepsis
refer to renal team for opinion early
if more than one organ dysfunction –> ITU
treat metabolic acidodis
relieve obstructios

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how to treat hyperkalaemia in AKI

A

stabilize cardiac membrane with 10ml 10% calclium gluconate

drive K into cells with 10 units actrapid in 50ml 20% glucose

beta agonists may also be used e.g. 2.5mg nebulised salbutamol

Additional: stop or adjust potassium-sparing or potassium-containing medications. Resins can reduce potassium absorption but these take hours/days to have effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

when to contact the renal team for urgent dialysis in an AKI (or ITU can also do this)

A
  • hyperkalaemia unresponsive to medical treatment or in an oliguric patient
  • pulmonary oedema unresponsive to medical treatment
  • uraemic complications like pericarditis, encephalopathy
  • severe metabolic acidosis (pH<7.2 or BE below -10)
  • fluid overload
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ECG changes in hyperkalaemia

A
peaked T waves
prolonged PR segment
loss of P wave
prolonged QRS
ST elevation 
ectopics
sine wave
VF
systole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

haematuria definition

A

> 5 RBCs per high power field

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

CKD definition

A

proteinuria or haematuria and/or a reduction in GFR <60ml/min/1.73m2 for more than 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

causes of CKD

A

DM - most common cause
HTN

less frequent causes

  • polycystic kidney disease
  • obstructive uropathy
  • focal segmental glomerulosclerosis
  • membranous nephropathy
  • lupus nephritis
  • amyloidosis
  • vasculitis
  • myeloma
  • rapidly progressive glomerulonephritis
  • nephrotoxic drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

nephrotoxic drugs

A

aminoglycosides (gentamicin), ACEi, ARBs, bisphosphates, calcineurin inhibitors (ciclosporin, tacrolimus), diuretics, lithium, mesalazine (5-ASA), NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

presentation of CKD

A

majority are asymptomatic and diagnosed by lab studies
will start to develop non-specific symptoms at more advanced stages
fatigue due to anaemia
anorexia and nausea
oedema and raised JVP due to salt and water retention
HTN
foamy urine (proteinuria)
dyspnoea (pulmonary oedema) peripheral neuropathy due to uraemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

grading of CKD

6 GFR stages and 3 albuminuria categories

A

Stage 1 /G1 kidney damage with normal or increased GFR, ≥90 mL/minute/1.73m²
Stage 2 /G2 kidney damage with mild decrease in GFR, 60 to 89 mL/minute/1.73m²
Stage 3a /G3a kidney damage with moderate decrease in GFR, 45 to 59 mL/minute/1.73m²
Stage 3b /G3b kidney damage with moderate decrease in GFR, 30 to 44 mL/minute/1.73m²
Stage 4 /G4 kidney damage with severe decrease in GFR, 15 to 29 mL/minute/1.73m²
Stage 5 /G5 kidney failure (end-stage kidney disease), with GFR <15 mL/minute/1.73m²

+

A1 Normal to mildly increased <3mg/mmol
A2 Moderately increased 3-29mg/mmol
A3 Severely increased >30mg/mmol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

investigations for CKD

A

BLOODS

  • serum creatinine for eGFR
  • calcium phosphate vitamin D and PTH tests
  • bicarbonate via an ABG or VBG
  • lipid profile
  • FBC for anaemia
  • ANA for SLE, ANCA for vasculitis
  • serum and urine free light chains and/or protein electrophoresis for myeloma

URINE

  • urinarlysis
  • albumin creatinine ratio
  • urine culture to exclude infection
  • electophoresis in myeloma

IMAGING

  • US with LUTS
  • CT-KUB for stones
  • ECG because are at high risk of CVS disease

CONSIDER
- renal biopsy- useful if glomerulonephritis is supsected

23
Q

management of CKD

A
  • stop nephrotoxic drugs
  • manage lifestyle factors
  • assess risk of CVD
  • give sources of info
  • advise to avoid use of oral NSAIDs where possible
  • maintain target BP with ACEi or RBS
  • NICE say all people with CKD should have a statin for prevention of CKD
  • K restriction in diet if hyperkalaemic
  • avoid high phosphate foods - milk, egg, cheese
  • vitamin D analogues (e.g. alfacalcidol)
  • replace iron/B12/folate if anaemic - if still anaemic can consider recombinant human EPO
  • sodium bicarb for acidosis
  • diureitcs (furosemide) for oedema

stage 5 - dialysis or kidney transplant

24
Q

target BP in CKD

A

<130/80

in diabetics or ACR >70 then <125/75

25
Q

nephrotic syndrome - 4 Os

A

prOteinuria >3.5g/24 hours
hyperlipidaemia (O = fat)
hypOalbuminaemia <30g/L
peripheral Oedema

may also have haematuria

26
Q

general treatment for nephrotic syndrome - SCAVAD

A

Salt +/- water restriction (be careful with this though)

treat underlying Cause

ACEi or ARBs (for HTN and proteinuria)

VTE prophylaxis ((relatively lose more antithrombotic than prothrombotic factors)

are risk of infection (variation in practice as to whether you give prophylactic Abx).

loop Diuretics for oedema

SCAVAD

27
Q

nephritic syndrome 3H’s + U

A

HTN
haematuria (usually non-visible)
hardly any urine (oliguira)
uraemia

may also have oedema
and proteinuria but <3.5g/24 hours

28
Q

nephrotic vs nephritic pathophysiology

A

nephrotic is a consequence of structural changes in the glomeruli in response to glomerular injury - podocytes lose foot processes

nephritic is associated with a proliferative response within the glomeruli leading to marked increase in cellularity (mesangial and endothelial proliferation and inflammatory cell infiltration)

29
Q

glomerulonephritis causes that can present as both nephrotic and nephritic syndrome

A

membranous GN
rapidly progressive GN
post-strep GN

30
Q

cause of primary nephritic syndrome

A

IgA nephropathy (Berger’s disease)

31
Q

6 causes of secondary nephritic syndrome

A
post-strep GN
SLE
Wegener's granulomatosis/granulomatosis with polyangiitis 
microscopic polyangitis
Henoch-Schlonlein purpura
Goodpasture's syndrome
32
Q

3 causes of primary nephrotic syndrome

A

minimal change disease
focal segmental glomerulosclerosis
membranous nephropathy

33
Q

4 causes of secondary nephrotic syndrome

A

diabetic nephropathy
SLE
amyloidosis
hepatitis B/C

34
Q

post streptococcal glomerulonephritis

A

almost extinct in western europe
presents 1-12 weeks after a sore throat/skin infection due to cross reaction of antibodies to group A haemolytic streptococcus
a type 3 hypersensitivity reaction

treatment is supportive

35
Q

investigations for post strep glomerulonephritis

A

light microscopy shows proliferation of mesangial cells, immune cells

immunofluoresnce shows IgG and C3 deposits - a lumpy-bumpy complex deposition

blood shows increased C3 and anti-streptolysin O

36
Q

Tetrad of Henoch-Schlonlein purpura

A

purpuric rash
abdominal pain
arthritis/arthralgia
glomerulonephritis

37
Q

diagnosis of Henoch-Schlonlein purpura

A

usually clinical using the tetrad

but can be condirmed with positive immunofluroresence for IgA and C3 in skin or renal biopsy

38
Q

diagnosis of granulomatosis with polyangiitis

A

a postitive c-ANCA test in the setting of typical otorhinolaryngeal, lung and renal involvement is suffieicnt

demonstation of necrotising vasculitits and grnaulomatous inflammation on tissue biopsy can also confirm (a negative ANCA does not exclude)

39
Q

treatment of granulomatosis with polyangiitis

A

2 stages - remission induction and remission maintenance

IV methylprednisolone or oral prednisolone for active GPA with cylophosphamide

then remission with prednisolone for active GPA and cyclophosphamide

40
Q

microscopic polyangiitis

A

Diagnosis: p-ANCA is positive in almost all cases. High CRP/ESR. Proteinuria and haematuria

treatment is long term prednisolone and cyclophosphamide

plasmapheresis can be helpful to acutely remove p-ANCA antibodies

41
Q

goodpasture’s syndrome

A

caused by autoantibodies to type IV collagen - an essential part of the glomerular basement membrane

type 2 hypersensitivity reaction

treat with plasmapheresis, IV prednisolone +/- cytotoxics (cyclophosphamide)

42
Q

membranous nephropathy - patholopysiology and presentation

A

bimodal peak in age in 20s and 60s
is caused by immune complex deposition which results in copmlement activation against glomerular BM proteins

patients typically present with oedema or HTN. May also report foamy urine or non-specific symptoms. Or could be an incidental finding on urinalysis

43
Q

causes of membranous nephorpathy

A

2/3rds are associated with autoantibodies to phospholipase A2 receptor (are idiopathic)

other 1/3 is secondary to malignancy, rheumatoid disorders, hep B, malaria, drugs

44
Q

diagnosis of membranous nephropathy

A

renal biopsy = diagnostic standrard

light microscopy shows thickened glomerular BM with IgG and complement deposits and thickened cappillary walls

immunofluroescence shows IgG and C3

45
Q

rule of thirds with membranous nephropathy

A

One-third remain with MGN indefinitely, one-third remit, and one-third progress to ESRF

46
Q

treatment of membranous nephropathy

A

Treat HTN, treat hyperlipidaemia, oedema (furosemide), steroids + cytotoxic or immunosuppressive therapy if medium or high risk of progression to ESRF

47
Q

most common cause of nephrotic syndrome in children

A

minimal change disease (kids = minimal age, foot = minimal body part)

48
Q

minimal change disease

A

effacement of foot processes
Onset is gradual, ranging from a few days to several weeks, and often follows a recent viral illness (suggested immune system involvement)

presents with facial or generalised oedema

49
Q

treatment of minimal change disease

A

corticosteroids and supportive care - reducing oedema

90% of children and 80% of adults respond well – often cured after 3 months

50
Q

most common cause of nephrotic syndrome in adults

A

focal segmental glomerulosclerosis (remember this is a primary cause of nephrotic syndrome)

51
Q

causes of focal segmental glomerulosclerosis

A

can be primary (genetic mutations) or secondary to HIV, IV drug use (heroin), sick cell disease

52
Q

investigations for focal segmental glomerulosclerosis

A

renal biopsy is required

light microscopy shows sclerosed lesions

antibody tests are all negative

immunofluroscence won’t show anything (might be some IgM and complement)

ECM will show GBM thickening and effacement of foot processes

53
Q

management of focal segmental glomerulosclerosis

A

salt restriction and diuretics to reduce oedema, antihypertensives, statins, cytotoxic drugs are sometimes useful, transplant is often required (50% progress to renal failure) (steroids can be used but have an inconsistent response)

And treat underlying cause if secondary